How to Read KLOW COA — Peptide Purity Report Guide

Most researchers never read past the purity percentage on a Certificate of Analysis. And that's the mistake that compromises half the experiments using peptides. The headline number (98%, 99.5%, etc.) tells you almost nothing about whether the batch is fit for your protocol. What matters is the chromatogram baseline, the mass spec fragmentation pattern, and whether the endotoxin load exceeds what your cell model tolerates. Our team has reviewed thousands of COAs across peptide suppliers, and we've learned that the most critical quality markers are buried three pages deep in data most people never open.

Here's what sets apart researchers who get reproducible results from those who don't: they know how to read KLOW COA documents as verification tools, not marketing claims. The COA is a forensic document. It captures every impurity, every synthesis artefact, and every storage failure that occurred between synthesis and shipping. If you can't interpret an HPLC trace or identify an acceptable mass spec delta, you're trusting the supplier's summary without independent verification. This article covers how to read KLOW COA reports step-by-step, what each analytical method reveals, and which flags invalidate a batch regardless of the purity claim.

What does it mean to 'read KLOW COA' for research peptides?

To read KLOW COA means to systematically verify peptide identity, purity, and sterility by interpreting High-Performance Liquid Chromatography (HPLC) chromatograms, Mass Spectrometry (MS) data, and endotoxin assay results. Not just accepting the summary purity percentage. KLOW is the naming convention used by some peptide synthesis facilities to designate batch-specific analytical reports, where each section maps to a different quality control checkpoint. A properly interpreted COA identifies synthesis impurities, degradation products, and microbial contamination that compromise experimental validity.

The gap most people miss: COAs are not standardised across suppliers. Some include only HPLC purity, while others add MS confirmation, amino acid analysis, and LAL endotoxin quantification. Knowing what each test reveals. And what it doesn't. Is what separates valid research from wasted protocol runs. We've worked with researchers who thought they were using 99% pure peptides until they learned their supplier's COA lacked MS confirmation, meaning the 'purity' measurement captured only one structural form and missed truncated fragments entirely.

This article covers three core skills: interpreting HPLC chromatograms to spot synthesis impurities, using mass spec data to confirm molecular weight within acceptable tolerance, and validating endotoxin levels for cell-based assays. It also explains what to do when a COA is incomplete, how to request additional testing, and which red flags mean you should reject a batch outright before reconstitution.

Step 1: Locate and Download the Batch-Specific COA From Your Supplier

Every research-grade peptide shipment must include a batch-specific COA. Not a generic product datasheet. The batch number on the vial label must match the batch number on the COA document exactly. Generic datasheets show representative data from a 'typical' batch, which tells you nothing about the specific peptide you received. Start by checking your supplier's website, order confirmation email, or product packaging for a COA download link or QR code tied to your batch number.

If the COA isn't included automatically, contact the supplier and request it using the exact batch identifier printed on your vial. Reputable peptide synthesis facilities provide COAs within 24–48 hours of request. If a supplier cannot or will not provide a batch-specific COA, that's a hard stop. Do not use the peptide. COA availability is the baseline standard for research-grade material; its absence means you have no independent verification of what's in the vial.

Once you have the document, verify it contains at least three sections: HPLC purity analysis, mass spectrometry confirmation, and peptide sequence. Endotoxin testing (LAL assay) should also be present for any peptide intended for cell culture or in vivo work. If any of these sections are missing, the COA is incomplete, and you should request the missing data before proceeding.

Step 2: Interpret the HPLC Chromatogram to Verify Purity and Spot Impurities

The HPLC section is where most people stop reading. They see '98.5% purity' and move on. But the chromatogram itself reveals what that percentage actually means. HPLC (High-Performance Liquid Chromatography) separates a peptide sample into its components based on retention time, producing a graph where each peak represents a distinct molecular species. The tallest peak is your target peptide; smaller peaks are impurities. Truncated sequences, deletion peptides, or synthesis by-products.

To read KLOW COA HPLC data correctly, look at the baseline first. A flat, stable baseline (near-zero signal between peaks) indicates clean separation and accurate integration. A drifting or noisy baseline suggests column degradation, improper solvent gradients, or sample contamination. All of which compromise the reliability of the purity calculation. If the baseline rises steadily across the chromatogram, the stated purity may be inflated by 2–5 percentage points because impurity peaks are hidden under baseline drift.

Next, examine the integration method used to calculate purity. The COA should state whether purity was determined by peak area normalisation (area under the curve for all peaks) or UV absorbance at a specific wavelength (typically 214 nm or 280 nm). Area normalisation is the gold standard. It accounts for all UV-active species in the sample. If the method isn't specified, the purity claim is unreliable. Count the number of impurity peaks visible above the baseline: more than 3–4 significant peaks (each >1% area) suggests incomplete purification, even if the headline purity is above 95%.

Step 3: Confirm Molecular Weight Using Mass Spectrometry Data and Acceptable Tolerance Ranges

HPLC tells you purity by separation; mass spectrometry (MS) tells you identity by molecular weight. The MS section of a COA should list the calculated molecular weight (based on the peptide sequence) and the observed molecular weight (measured from the sample). These two numbers will never match exactly due to instrument precision, but the delta must fall within acceptable tolerance. Typically ±0.05% for electrospray ionisation (ESI-MS) or ±1 Da for MALDI-TOF.

To read KLOW COA mass spec data, compare the expected mass to the observed mass. For a peptide with a calculated mass of 2,500 Da, an observed mass of 2,501.3 Da is acceptable. An observed mass of 2,485 Da or 2,530 Da is not. It indicates the peptide is truncated, modified, or contaminated with a structurally similar impurity that HPLC didn't fully resolve. Mass spec is the definitive identity check; if the molecular weight doesn't match, you don't have the peptide you ordered.

Some COAs report MS data as a spectrum rather than a single value. In these cases, look for the base peak (the tallest peak in the spectrum). This represents the most abundant ion form of your peptide. Minor peaks at ±18 Da or ±23 Da relative to the base peak are usually sodium or potassium adducts (peptide + Na⁺ or K⁺), which are normal and don't indicate impurity. Peaks separated by more than 50 Da, however, suggest fragmentation, deletion sequences, or oxidation by-products.

KLOW COA Sections: What Each Test Reveals and Why It Matters

Key Takeaways

• To read KLOW COA correctly, verify the batch number on your vial matches the COA document exactly. Generic datasheets are not batch-specific verification.
• HPLC purity is only meaningful if the chromatogram shows a flat baseline and fewer than four impurity peaks above 1% area each.
• Mass spectrometry confirms peptide identity by molecular weight; an observed mass more than 1 Da from the calculated mass indicates the peptide is not what you ordered.
• Endotoxin testing (LAL assay) is mandatory for cell culture and in vivo work. Levels above 1.0 EU/mg compromise experimental validity in most protocols.
• A drifting HPLC baseline, missing MS data, or absent endotoxin testing are all grounds to reject a batch before reconstitution.

What If: KLOW COA Scenarios

What If the HPLC Purity Looks Good But the Baseline Drifts Upward Across the Chromatogram?

Request a re-analysis with a fresh column or a different solvent gradient. A drifting baseline means the purity calculation is unreliable. Impurities may be hidden under the drift, artificially inflating the target peak percentage. If the supplier cannot or will not rerun the analysis, consider the peptide suspect and do not use it in experiments where purity directly affects the outcome (dose-response curves, receptor binding assays, mechanistic studies). Baseline drift of more than 5 mAU (milliabsorbance units) over the chromatogram duration is a red flag.

What If the Mass Spec Shows the Correct Molecular Weight But HPLC Purity Is Only 92%?

The peptide is correctly synthesised but incompletely purified. The 8% impurity consists of structurally similar peptides (deletion sequences, protected amino acids, or truncated forms) that don't affect molecular weight enough to shift the MS base peak but do appear as separate HPLC peaks. For some applications (screening assays, preliminary dose-finding), 92% is acceptable. For quantitative work (IC50 determination, structural studies, pharmacokinetics), it's not. The impurities introduce variability you can't correct for. Use it only if you can verify the impurities are biologically inert in your specific assay.

What If the COA Lists Endotoxin as 'Not Tested' But You Need the Peptide for Cell Culture?

Do not use it until you obtain endotoxin data. Contact the supplier and request LAL (Limulus Amebocyte Lysate) testing for your specific batch. If they cannot provide it, either send a sample to a third-party testing lab for independent LAL analysis (cost: approximately 150–300 USD per sample, turnaround 5–7 days) or accept that the peptide is unsuitable for cell-based work. Endotoxin contamination as low as 0.5 EU/mg can alter cytokine expression, immune cell activation, and apoptosis rates. Rendering your results uninterpretable.

The Unvarnished Truth About COA Quality Across Peptide Suppliers

Here's the honest answer: most peptide suppliers issue COAs that meet the minimum threshold for regulatory compliance but omit the data you actually need to make an informed decision. A document labelled 'Certificate of Analysis' doesn't guarantee completeness. Some suppliers provide HPLC-only COAs with no MS confirmation, no endotoxin testing, and no amino acid analysis. This isn't fraud; it's cost optimisation. Running a full five-part COA (HPLC, MS, AAA, LAL, Karl Fischer) costs the supplier 200–400 USD per batch. Many skip the expensive tests unless you explicitly request them.

The peptide research market includes suppliers operating under widely different quality standards. Academic core facilities and GMP-certified contract manufacturers provide exhaustive COAs because their customers demand traceability. Budget suppliers targeting hobbyist or grey-market users provide minimal documentation because their customers prioritise price over verification. If you're comparing peptides based solely on cost per milligram, you're almost certainly sacrificing COA completeness. The 50 USD per vial you save now costs you three weeks of failed experiments later when you discover the peptide was 89% pure, not 98%.

We mean this sincerely: if a supplier cannot provide MS confirmation and endotoxin data within 48 hours of request, find another supplier. COA quality is the single clearest predictor of peptide quality, and there is no scenario where saving money on a peptide justifies compromising your research timeline. Real Peptides provides batch-specific COAs with HPLC, MS, and endotoxin data for every synthesis lot, so you know exactly what you're working with before you reconstitute it.

How to Request Missing COA Data When the Provided Document Is Incomplete

If your COA lacks MS data, endotoxin testing, or amino acid analysis, email the supplier using this template: 'Batch [number] COA is missing [specific test]. Please provide [HPLC chromatogram / mass spectrum / LAL endotoxin assay / AAA report] for this batch or confirm whether this testing was performed. If not performed, please provide an estimated timeline and cost for retroactive testing.' Professional peptide suppliers will respond within 24–48 hours with either the missing data or an explanation of why it wasn't included (e.g., endotoxin testing not standard for non-sterile peptides).

If the supplier cannot provide the data and cannot perform the test retroactively, your options are: (1) accept the peptide as-is and document the missing verification in your research records, (2) send a sample to an independent analytical lab for third-party testing (HPLC re-analysis: 150–250 USD; MS confirmation: 100–200 USD; LAL endotoxin: 150–300 USD), or (3) reject the batch and request a replacement from a lot with complete COA documentation. Option 3 is the only choice that doesn't compromise your data integrity.

Some suppliers will argue that MS testing is 'not necessary' if HPLC purity is above 98%. This is categorically false. HPLC measures purity by separation; MS measures identity by molecular weight. A peptide can be 98% pure by HPLC and still be the wrong peptide entirely if the synthesis failed at the coupling stage. MS is non-negotiable for any experiment where peptide identity affects the biological outcome. Which is essentially every experiment. Do not accept a COA without it.

Reading a COA isn't gatekeeping. It's basic experimental hygiene. The same researchers who wouldn't dream of running a Western blot without a loading control routinely inject peptides without verifying the molecular weight matches the sequence. Those small black-and-white chromatograms buried on page three of the PDF are the difference between reproducible science and noise.